Corentec Co

Corentec Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Corentec Co (104540.KQ) as of Nov 5, 2026 is 0.23. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.36 — a change of -35.21% (lower).

PEG

0.23

YoY

-35.21%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Corentec Co is 2025 0.23 . PEG Ratio (Price/Earnings-to-Growth) of Corentec Co was 2024 0.36 . It decreases by -35.21% lower compared to the previous year.

The Corentec Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2016
3.10 KRW
Jan 1, 2019
0.58 KRW
Jan 1, 2020
0.92 KRW
Jan 1, 2021
1.89 KRW
Jan 1, 2022
0.81 KRW
Jan 1, 2023
0.36 KRW
Jan 1, 2025
0.23 KRW
The Corentec Co PEG history
YEARPEGYoY
0.23-35.21%
0.36-56.09%
0.81-57.10%
1.89+106.06%
0.92+59.17%
0.58-81.39%
3.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

PEG Ratio (Price/Earnings-to-Growth) of Corentec Co is 0.23 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Corentec Co changed from 0.36 to 0.23, representing a -35.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Corentec Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Corentec Co

All Key Metrics — Corentec Co